Urokinase-type plasminogen activator (uPA) and its inhibitors, plasminogen activator inhibitor type-1 and type2 (PAI-1 and PAI-2), are crucial in tumor invasion and metastasis. This evidence concerns the gene PLAU and neoplasm.